FOI release
Unlicensed medication importation
Some or all of the information requested was not provided because we determined that the cost to do so would exceed the appropriate limit.
Case reference FOI2026/00932
Received 22 August 2026
Published 7 October 2026
Request
Dear MHRA, I am writing to request information under the Freedom of Information Act 2000 relating to notifications of intent to import selected unlicensed medicinal products into the United Kingdom. For the period 1 January 2025 to the most recent date for which data are available, please provide information held by the MHRA relating to notifications to import the following substances: * Testosterone cypionate * Testosterone enanthate * Testosterone – other formulations * Human chorionic gonadotrophin (hCG / chorionic gonadotrophin) * Enclomifene / enclomiphene * Sermorelin * Tesamorelin * Ipamorelin * CJC-1295 * BPC-157 * Glutathione * NAD / NAD+ / nicotinamide adenine dinucleotide * Levocarnitine / L-carnitine For each notification, where held, I would be grateful if the following fields could be provided: * Non-proprietary/generic name (INN/BAN) * Proprietary/product name * Strength * Pharmaceutical form * Route of administration * Pack size * Number of packs notified for import * Country of manufacture * Country from which the product was supplied/imported * Manufacturer * Importer * Importer’s WDA(H) or Manufacturer’s “Specials” Licence number * Date or month/year of notification * Whether the MHRA raised no objection, requested further information, or objected to the importation I would preferably like the information supplied electronically in CSV or Excel format. If any individual field cannot be disclosed because an exemption applies, I would be grateful if you could provide the remaining non-exempt fields rather than refusing the request in its entirety. If providing notification-level data would exceed the appropriate cost limit under section 12 of the Freedom of Information Act, I would instead be grateful for aggregated data by substance and calendar year, including, where held: * Number of import notifications * Total number of packs notified * Countries of manufacture * Countries of supply * Manufacturers * Importers If the request would still exceed the appropriate cost limit, please advise what narrower date range, subset of substances or level of aggregation would allow the request to be fulfilled.
Response
See attached
Documents
This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.